Literature DB >> 10201603

Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration.

P T Merrill1, F J LoRusso, M D Lomeo, S J Saxe, M M Khan, H M Lambert.   

Abstract

OBJECTIVE: To assess the results of surgical excision of subfoveal choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD).
DESIGN: Retrospective, interventional, noncomparative case series. PARTICIPANTS AND INTERVENTION: Sixty-four consecutive patients undergoing surgical removal of AMD-related subfoveal CNV were studied. The surgical method included a small retinotomy, subretinal tissue plasminogen activator (t-PA), perfluoro-n-octane, and air-fluid exchange. MAIN OUTCOME MEASURES: Final visual acuity was the main outcome measure; surgical complications and recurrence rates were also assessed.
RESULTS: Preoperative visual acuity ranged from 20/100 to 1/200, with a mean of 20/400. Average follow-up was 19 months. The best acuity achieved after surgery ranged from 20/20 to hand motions, with a mean of 20/200. Final visual acuity ranged from 20/50 to light perception, with a mean of 20/400. Final acuity was improved 3 or more lines in 19 eyes (30%) (median, 5 lines), stable in 27 eyes (42%), and 3 or more lines worse in 18 eyes (28%) (median, 4 lines). Factors associated with greater visual improvement included poorer initial acuity, larger CNV size, and smaller subretinal hemorrhage. Analysis of groups similar to Macular Photocoagulation Study subgroups A through D showed an average improvement of 1 line for group C (visual acuity, 20/200 or worse; CNV larger than 2 disc areas). Other preoperative, intraoperative, and postoperative factors, including recurrence and retinal detachment, did not have a significant effect on final visual outcome.
CONCLUSIONS: After surgical excision of AMD-related subfoveal CNV, vision improved or stabilized in the majority of patients. Surgery may be of greatest value for patients with poorer vision, larger subfoveal CNV, and minimal hemorrhage. Further evaluation of this technique should be accomplished via completion of a controlled, randomized multicenter study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201603     DOI: 10.1016/S0161-6420(99)90167-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

Review 1.  Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.

Authors:  G Soubrane; N M Bressler
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

Review 2.  Basement membranes and artificial substrates in cell transplantation.

Authors:  Carl Sheridan; Rachel Williams; Ian Grierson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-20       Impact factor: 3.117

3.  Translocation of iris pigment epithelium in patients with exudative age-related macular degeneration: long-term results.

Authors:  Alexandra Lappas; Andreas M H Foerster; Andreas W A Weinberger; Silke Coburger; Norbert F Schrage; Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-06       Impact factor: 3.117

4.  Choroidal translocation with a pedicle following excision of a type 1 choroidal neovascular membrane.

Authors:  R I Angunawela; T H Williamson; M A J Khan; V Chong
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 5.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  The end of submacular surgery for age-related macular degeneration? A meta-analysis.

Authors:  Christiane I Falkner; Harald Leitich; Florian Frommlet; Peter Bauer; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-05-04       Impact factor: 3.117

7.  Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membrane.

Authors:  Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 8.  Age-related macular degeneration and retinal pigment epithelium wound healing.

Authors:  Ilene K Sugino; Hao Wang; Marco A Zarbin
Journal:  Mol Neurobiol       Date:  2003-10       Impact factor: 5.590

Review 9.  Current concepts and recent advances in the management of age-related macular degeneration.

Authors:  S Byrne; S Beatty
Journal:  Ir J Med Sci       Date:  2003 Oct-Dec       Impact factor: 1.568

10.  Human embryonic stem cell-derived retinal pigment epithelium transplants as a potential treatment for wet age-related macular degeneration.

Authors:  Yong Liu; Hai Wei Xu; Lei Wang; Shi Ying Li; Cong Jian Zhao; Jie Hao; Qi You Li; Tong Tao Zhao; Wei Wu; Yi Wang; Qi Zhou; Cheng Qian; Liu Wang; Zheng Qin Yin
Journal:  Cell Discov       Date:  2018-09-11       Impact factor: 10.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.